This company is no longer active
La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Zosano Pharma Bilan de santé
Santé financière contrôle des critères 4/6
Informations clés
0%
Ratio d'endettement
US$0
Dette
Ratio de couverture des intérêts | n/a |
Argent liquide | US$13.53m |
Fonds propres | US$14.05m |
Total du passif | US$12.39m |
Total des actifs | US$26.45m |
Mises à jour récentes de la santé financière
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Recent updates
Can Zosano Pharma (NASDAQ:ZSAN) Afford To Invest In Growth?
Nov 02Is Zosano Pharma (NASDAQ:ZSAN) Weighed On By Its Debt Load?
Jun 29Data supports long-term benefit of Zosano's migraine candidate; shares surge 23%
May 26Zosano Pharma: Early PK+Safety Study In Q3 2021 May Breathe New Life Into This Biotech
Apr 30Zosano shares rise on migraine treatment NDA resubmission update
Apr 26Auditors Have Doubts About Zosano Pharma (NASDAQ:ZSAN)
Mar 15Zosano Pharma up 21% following FDA feedback on Qtrypta application; presents Qtrypta data in migraine
Feb 01Zosano Pharma requests FDA meeting for its Qtrypta application
Jan 04Zosano Pharma EPS misses by $0.01
Nov 13Analyse de la situation financière
Passif à court terme: ZSAN.Q's short term assets ($15.6M) exceed its short term liabilities ($9.7M).
Passif à long terme: ZSAN.Q's short term assets ($15.6M) exceed its long term liabilities ($2.7M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: ZSAN.Q is debt free.
Réduire la dette: ZSAN.Q has no debt compared to 5 years ago when its debt to equity ratio was 39.1%.
Bilan
Analyse des pistes de trésorerie
Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.
Piste de trésorerie stable: ZSAN.Q has less than a year of cash runway based on its current free cash flow.
Prévisions de trésorerie: ZSAN.Q has less than a year of cash runway if free cash flow continues to reduce at historical rates of 7.4% each year